ILDSTAD SUZANNE (Chief Scientific Officer) sold 2.4% of their position (68.74K shares) of TOURMALINE BIO, INC. on the open market
Open‑market sale worth $156.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 4/21/2023ACC: 0001209191-23-025040
DirectorOfficer10% Owner· Chief Scientific Officer
Since May 2021
-68.74K
Net shares
Net seller
$156.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
68.74K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−21.75K
Price / share
$2.16
Trade value
$47.06K
% of position
0.7%
4/19/2023
2.91M→2.88M
Common Stock
Direct
Shares
−46.99K
Price / share
$2.33
Trade value
$109.31K
% of position
1.6%
4/20/2023
2.88M→2.84M
Total
Net shares
−68.74K
Net value
-$156.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/19/2023 | S · Sale | −21.75K | $2.16 | $47.06K | 0.7% | 2.91M | 2.88M |
| Common Stock Direct | 4/20/2023 | S · Sale | −46.99K | $2.33 | $109.31K | 1.6% | 2.88M | 2.84M |
| Total | −68.74K | -$156.37K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned654.21K
Common Stock
IndirectShares owned654.21K
Common Stock
IndirectShares owned1.20M
Total
2.51M indirect2.51M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 654.21K | Indirect |
| Common Stock | 654.21K | Indirect |
| Common Stock | 1.20M | Indirect |
| Total | 2.51M | 2.51M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported